Patent details
EP3107577 Title: DISEASE THERAPY BY INDUCING IMMUNE RESPONSE TO TROP-2 EXPRESSING CELLS
Basic Information
- Publication number:
- EP3107577
- PCT Application Number:
- US2015012010
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP157520875
- PCT Publication Number:
- WO2015126548
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- DISEASE THERAPY BY INDUCING IMMUNE RESPONSE TO TROP-2 EXPRESSING CELLS
- French Title of Invention:
- TRAITEMENT D'UNE MALADIE PAR INDUCTION D'UNE RÉPONSE IMMUNE À DES CELLULES EXPRIMANT LE TROP-2
- German Title of Invention:
- KRANKHEITSTHERAPIE DURCH INDUKTION EINER IMMUNANTWORT GEGEN TROP-2-EXPRIMIERENDE ZELLEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 18/04/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 25/04/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 20/03/2024
- Unitary Effect Registration Date:
- 25/04/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 20/01/2015
- Grant date:
- 20/03/2024
- EP Publication Date:
- 28/12/2016
- PCT Publication Date:
- 27/08/2015
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 20/03/2024
- EP B1 Publication Date:
- 20/03/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 20/01/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 13/03/2024
- Name:
- IBC Pharmaceuticals, Inc.
- Address:
- 300 American Road, Morris Plains, NJ 07950, United States (US)
Inventor
1
- Name:
- GOLDENBERG, David M.
- Address:
- United States (US)
2
- Name:
- CHANG, Chien-Hsing
- Address:
- United States (US)
3
- Name:
- ROSSI, Edmund A.
- Address:
- United States (US)
4
- Name:
- ROSSI, Diane
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201461942752 P
- Priority Date:
- 21/02/2014
- Priority Country:
- United States (US)
2
- Priority Number:
- 201462049826 P
- Priority Date:
- 12/09/2014
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 39/395; C07K 16/00; C07K 16/28; C07K 16/30; A61K 39/00; A61P 35/00; A61P 1/04; A61P 1/18; A61P 11/00; A61P 13/08; A61P 13/10; A61P 13/12; A61P 15/00; A61P 37/04; A61P 43/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202412
- Publication date:
- 20/03/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202421
- Publication date:
- 22/05/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202422
- Publication date:
- 29/05/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|